Wertpapierdatensatz · archiviertes Quartal
AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
22Erfasste Halter
-1Δ Inhaber
189.68MGehaltene Aktien
$13.26BGemeldeter Wert
+0Neue Positionen
−1Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -4.3% ·
Aktienfluss -4.1% ·
neue Nettopositionen -4.5%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 156 | +6 | 601.54M | $113.17B | +11 | −4 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | — | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | — | — |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | — |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | — | −3 |
| Q2 2024 | 20 | — | 172.48M | $13.45B | — | — |
Wer es hält · Q2 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 51.94M | -9.0% | $3.63B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 51.94M | -9.0% | $3.63B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 41.20M | +1.3% | $2.88B | 2.3% | ▲ Add | 5 | SEC ↗ |
| 4 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 20.70M | +2.6% | $1.45B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 19 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | BlackRock ✦ (passiv) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Marshall Wace ✦ | 2.00M | +45.3% | $139.76M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 31 | Marshall Wace ✦ | 2.00M | +45.3% | $139.76M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 1.90M | +12.2% | $133.12M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 1.90M | +12.2% | $133.12M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 1.83M | -10.5% | $127.95M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 1.83M | -10.5% | $127.95M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 36 | Point72 Asset Management ✦ | 1.69M | +41.9% | $117.79M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 1.30M | +335.8% | $91.11M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 38 | Arrowstreet Capital ✦ | 1.16M | -67.8% | $80.75M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 39 | Millennium Management ✦ | 1.14M | +20.3% | $79.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 40 | State Street Global Advisors ✦ (passiv) | 939.00K | -6.0% | $65.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 858.50K | +88.9% | $59.99M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 42 | Bridgewater Associates ✦ | 620.90K | -10.2% | $43.39M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 43 | Geode Capital Management ✦ (passiv) | 505.06K | +2.9% | $35.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Adage Capital Partners ✦ | 325.39K | -49.7% | $22.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 45 | Capital World Investors ✦ | 153.56K | +2.8% | $10.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Dodge & Cox ✦ | 137.49K | +1.0% | $9.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Norges Bank ✦ (passiv) | 60.38K | +268.6% | $4.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Soros Fund Management | $201.57M | war 5.1% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 2 Inhaber, 42.58K Anteile, $8.26M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q2 2025 ·
Methodik ·
Über die API abrufen